Clinical Roundup Phase III VIALE-A trial of venetoclax combination meets OS endpoint in AML September 04, 2020Vol.46 No.33
Clinical Roundup Opdivo + Yervoy demonstrate durable survival benefit vs. chemotherapy in mesothelioma September 04, 2020Vol.46 No.33
Clinical Roundup Opdivo meets OS, PFS endpoints in phase III CheckMate-649 trial September 04, 2020Vol.46 No.33
Clinical Roundup Phase III IMpassion131 trial evaluating Tecentriq + paclitaxel does not meet PFS endpoint in metastatic TNBC September 04, 2020Vol.46 No.33
Clinical Roundup City of Hope clinical trial tests efficacy of delivering chemotherapy into the abdomen via a fine spray September 04, 2020Vol.46 No.33
Clinical Roundup Phase I/II relapsed or refractory Hodgkin lymphoma studies demonstrate high rate of durable complete responses September 04, 2020Vol.46 No.33
Clinical Roundup Study may refine predicted survival outcomes and treatment in younger adults with acute leukemia September 04, 2020Vol.46 No.33
Clinical Roundup CRUK-funded researchers use AI to analyze genetics of cancer September 04, 2020Vol.46 No.33
Clinical Roundup Genomic markers can identify brain tumor patients most likely to benefit from chemotherapy September 04, 2020Vol.46 No.33
